Murine model of femoral artery wire injury with implantation of a perivascular drug delivery patch.
Percutaneous interventions including balloon angioplasty and stenting have been used to restore blood flow in vessels with occlusive vascular disease. While these therapies lead to the rapid restoration of blood flow, these technologies remain limited by restenosis in the case of bare metal stents and angioplasty, or reduced healing and possibly enhanced risk of thrombosis in the case of drug eluting stents. A key pathophysiological mechanism in the formation of restenosis is intimal hyperplasia caused by the activation of vascular smooth muscle cells and inflammation due to arterial stretch and injury. Surgeries that induce arterial injury in genetically modified mice are useful for the mechanistic study of the vascular response to injury but are often technically challenging to perform in mouse models due to the their small size and lack of appropriate sized devices. We describe two approaches for a surgical technique that induces endothelial denudation and arterial stretch in the femoral artery of mice to produce robust neointimal hyperplasia. The first approach creates an arteriotomy in the muscular branch of the femoral artery to obtain vascular access. Following wire injury this arterial branch is ligated to close the arteriotomy. A second approach creates an arteriotomy in the main femoral artery that is later closed through localized cautery. This method allows for vascular access through a larger vessel and, consequently, provides a less technically demanding procedure that can be used in smaller mice. Following either method of arterial injury, a degradable drug delivery patch can be placed over or around the injured artery to deliver therapeutic agents.
Department of Biomedical Engineering, University of Texas at Austin.
Victoria
V
Le
Department of Biomedical Engineering, University of Texas at Austin.
Collin G
CG
Johnson
Department of Biomedical Engineering, University of Texas at Austin.
Jonathan D
JD
Lee
Department of Biomedical Engineering, University of Texas at Austin; abbaker@austin.utexas.edu.
Aaron B
AB
Baker
D000818:Animals; D004195:Disease Models, Animal; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D005263:Femoral Artery / Q000293:injuries*; D006965:Hyperplasia / Q000209:etiology; D051379:Mice; D019919:Prosthesis Implantation / Q000009:adverse effects* / Q000379:methods; D017539:Tunica Intima / Q000473:pathology